Using advanced protein biomarker approaches to better understand COVID-19

Webinar title: "Using advance protein biomarker approaches to better understand rare disease and COVID-19"

In this webinar, Dr. Frank Schmidt discusses two clinical studies run by the Weill Cornell Medicine Proteomics core using Olink protein assays to understand COVID-19. These two studies were then included in an inter-study comparison to find commonalities in the findings of important protein biomarkers in the disease.

Watch the webinar to learn more about:

• Dr. Schmidt's discovery that the same inflammatory proteins were elevated in patients suffering from ARDS resulting from COVID-19, influenza, and bacterial sepsis
• How Dr Schmidt combined metabolomic and proteomic data to compare patients who were hospitalized due to COVID-19 vs another disease
• Their findings of 37 proteins that were common in all five clinical studies that were compared in their meta analysis

Speaker